What this involves: Local anaesthesia is applied to numb the area
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
Improved Insulin Sensitivity (With Caution) In small, controlled doses, IGF-1 LR3 may improve insulin sensitivity by facilitating glucose uptake into muscle cells which also supports glycogen storage and performance
And this is the point of this, this is educational, right
GLP-1 therapies help regulate appetite and food intake and also support sustainable weight management